Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...

Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026 ...

Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ecosystems and its evolution during cancer progression. This conceptual framework ...

Proton beam therapy induced survival outcomes that were equal to or better than photon radiotherapy, and may represent a viable treatment option for some patients with pediatric neuroblastoma.

For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London ...

Abstract Endotrophin (ETP) is a cleavage fragment of collagen VI α3 (COL6A3) that functions as a potent fibrotic and pro-tumorigenic factor. ETP is a ...

Cholesterol enhances melanoma cell invasion by making nuclei squishier, revealing a potential treatment target in cancer progression.

Large genomic study of feline tumors identifies shared mutations with human cancers, strengthening comparative oncology research.

Despite a rapidly growing tumor in his hypopharynx, Nguyen Luong Loi refuses hospitalization and endures severe pain to save every penny for his nine-year-old daughter's chemotherapy.

A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal a cancer cure.

Public Erupts in Anger After CIA Finally Declassifies Document on Possible Cancer Cure Hidden for 60 Years ...